[Effectiveness of tyrosine kinase inhibitors against non-small cell lung cancer patients with postoperative recurrence harboring uncommon EGFR mutations]. [electronic resource]
Producer: 20171214Description: 732-736 p. digitalISSN:- 0253-3766
- Antineoplastic Agents -- therapeutic use
- Asian People
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- genetics
- Exons
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Mutagenesis, Insertional
- Mutation
- Neoplasm Recurrence, Local -- drug therapy
- Point Mutation
- Postoperative Period
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Retrospective Studies
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.